Drug Approval | March 09, 2023
Eugia Pharma receives USFDA approval for Lenalidomide Capsules
The approved product is indicated for the treatment of adult patients with Multiple myeloma, in combination with Dexamethasone
The approved product is indicated for the treatment of adult patients with Multiple myeloma, in combination with Dexamethasone
The new powder flow tester can characterize powder flow properties, offering valuable insight for pharmaceutical processing and formulation
lAIH strives to introduce appropriate interventions for nurturing an AMR innovation ecosystem in the country through cohesive efforts across the innovation pyramid
Smart-performance, fully biodegradable biopolymer sourced from renewable raw materials
The audit was commenced for newly renovated manufacturing Block 1, Block 2, and Block 3
Vigabatrin for Oral Solution USP, 500 mg had annual sales of US $233.7 mn in US
This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry
Vigabatrin for Oral Solution USP, 500 mg had annual sales of USD 233.7 mn in the United States
This order is subject to initial advance payment as per the agreed terms of the contract and this order will be executed within 6 to 8 months.
he product will be launched shortly in the US market.
Subscribe To Our Newsletter & Stay Updated
